Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Express Scripts
Chubb
Federal Trade Commission
Moodys
Baxter

Generated: April 23, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070172

« Back to Dashboard

NDA 070172 describes NALOXONE HYDROCHLORIDE, which is a drug marketed by Abraxis Pharm, Akorn, Astrazeneca, Eurohlth Intl Sarl, Hospira, Igi Labs Inc, Intl Medication, Marsam Pharms Llc, Mylan Institutional, Renaissance Ssa Llc, Smith And Nephew, Solopak, Somerset Theraps Llc, Watson Labs, Lupin, and Sun Pharm Inds Ltd, and is included in fifty NDAs. It is available from sixteen suppliers. Additional details are available on the NALOXONE HYDROCHLORIDE profile page.

The generic ingredient in NALOXONE HYDROCHLORIDE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
Summary for 070172
Tradename:NALOXONE HYDROCHLORIDE
Applicant:Hospira
Ingredient:naloxone hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 070172
Mechanism of ActionOpioid Antagonists
Medical Subject Heading (MeSH) Categories for 070172
Suppliers and Packaging for NDA: 070172
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 070172 ANDA Hospira, Inc. 0409-1782 0409-1782-69 10 CARTRIDGE in 1 BOX (0409-1782-69) > 1 mL in 1 CARTRIDGE (0409-1782-03)
NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 070172 ANDA HF Acquisition Co. LLC, DBA HealthFirst 51662-1238 51662-1238-1 1 mL in 1 CARTRIDGE (51662-1238-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.4MG/ML
Approval Date:Sep 24, 1986TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
Federal Trade Commission
Colorcon
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.